Dr Alexandra Gerassimides, MD | |
231 E Chestnut St, Pathology Dept, Louisville, KY 40202-1821 | |
(502) 456-6212 | |
(502) 456-4440 |
Full Name | Dr Alexandra Gerassimides |
---|---|
Gender | Female |
Speciality | Pathology |
Experience | 40 Years |
Location | 231 E Chestnut St, Louisville, Kentucky |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245233626 | NPI | - | NPPES |
50105848 | Other | KY | PASSPORT |
000000998707 | Other | KY | ANTHEM |
200044910A | Medicaid | IN | |
64255581 | Medicaid | KY |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 25558 (Kentucky) | Primary |
207ZP0213X | Pathology - Pediatric Pathology | 25558 (Kentucky) | Secondary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Pediatric And Perinatal Pathology Associates Psc | 5294708285 | 4 |
News Archive
Researchers from France and Hong Kong determined that transient elastography (TE), a noninvasive, ultrasonic imaging modality, can be accurately performed in the majority of patients with nonalcoholic fatty liver disease (NAFLD) to exclude advanced fibrosis. Full findings of this study, funded by the Chinese University of Hong Kong, appear in the February issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Biodesign Institute at Arizona State University associate research scientist Melha Mellata, a member of professor Roy Curtiss' team, is leading a USDA funded project to develop a vaccine against a leading poultry disease called avian pathogenic E. coli (APEC).
The Wall Street Journal: FDA is putting on workshops for pharmaceutical manufacturers to increase the pool of applicants for approved "orphan drugs," that treat rare diseases. Currently, there are about 7,000 so-called orphan diseases in the U.S. that have few or no FDA-approved treatments.
Planned births occur where a considered decision is made to deliver an infant, and in recent years there have been significant changes in clinical practice resulting in an increase in planned births before the ideal time of birth at 39-40 weeks' gestation.
› Verified 4 days ago
Entity Name | Clinical Associates Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831357797 PECOS PAC ID: 3577456300 Enrollment ID: O20040205000623 |
News Archive
Researchers from France and Hong Kong determined that transient elastography (TE), a noninvasive, ultrasonic imaging modality, can be accurately performed in the majority of patients with nonalcoholic fatty liver disease (NAFLD) to exclude advanced fibrosis. Full findings of this study, funded by the Chinese University of Hong Kong, appear in the February issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Biodesign Institute at Arizona State University associate research scientist Melha Mellata, a member of professor Roy Curtiss' team, is leading a USDA funded project to develop a vaccine against a leading poultry disease called avian pathogenic E. coli (APEC).
The Wall Street Journal: FDA is putting on workshops for pharmaceutical manufacturers to increase the pool of applicants for approved "orphan drugs," that treat rare diseases. Currently, there are about 7,000 so-called orphan diseases in the U.S. that have few or no FDA-approved treatments.
Planned births occur where a considered decision is made to deliver an infant, and in recent years there have been significant changes in clinical practice resulting in an increase in planned births before the ideal time of birth at 39-40 weeks' gestation.
› Verified 4 days ago
Entity Name | Pediatric And Perinatal Pathology Associates Psc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659306504 PECOS PAC ID: 5294708285 Enrollment ID: O20040817001393 |
News Archive
Researchers from France and Hong Kong determined that transient elastography (TE), a noninvasive, ultrasonic imaging modality, can be accurately performed in the majority of patients with nonalcoholic fatty liver disease (NAFLD) to exclude advanced fibrosis. Full findings of this study, funded by the Chinese University of Hong Kong, appear in the February issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Biodesign Institute at Arizona State University associate research scientist Melha Mellata, a member of professor Roy Curtiss' team, is leading a USDA funded project to develop a vaccine against a leading poultry disease called avian pathogenic E. coli (APEC).
The Wall Street Journal: FDA is putting on workshops for pharmaceutical manufacturers to increase the pool of applicants for approved "orphan drugs," that treat rare diseases. Currently, there are about 7,000 so-called orphan diseases in the U.S. that have few or no FDA-approved treatments.
Planned births occur where a considered decision is made to deliver an infant, and in recent years there have been significant changes in clinical practice resulting in an increase in planned births before the ideal time of birth at 39-40 weeks' gestation.
› Verified 4 days ago
Entity Name | Clinical Associates Llc |
---|---|
Entity Type | Part B Supplier - Independent Clinical Laboratory |
Entity Identifiers | NPI Number: 1881697464 PECOS PAC ID: 3577456300 Enrollment ID: O20060627000058 |
News Archive
Researchers from France and Hong Kong determined that transient elastography (TE), a noninvasive, ultrasonic imaging modality, can be accurately performed in the majority of patients with nonalcoholic fatty liver disease (NAFLD) to exclude advanced fibrosis. Full findings of this study, funded by the Chinese University of Hong Kong, appear in the February issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Biodesign Institute at Arizona State University associate research scientist Melha Mellata, a member of professor Roy Curtiss' team, is leading a USDA funded project to develop a vaccine against a leading poultry disease called avian pathogenic E. coli (APEC).
The Wall Street Journal: FDA is putting on workshops for pharmaceutical manufacturers to increase the pool of applicants for approved "orphan drugs," that treat rare diseases. Currently, there are about 7,000 so-called orphan diseases in the U.S. that have few or no FDA-approved treatments.
Planned births occur where a considered decision is made to deliver an infant, and in recent years there have been significant changes in clinical practice resulting in an increase in planned births before the ideal time of birth at 39-40 weeks' gestation.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Alexandra Gerassimides, MD 1941 Bishop Ln Ste 1018, Louisville, KY 40218-1928 Ph: (502) 456-6211 | Dr Alexandra Gerassimides, MD 231 E Chestnut St, Pathology Dept, Louisville, KY 40202-1821 Ph: (502) 456-6212 |
News Archive
Researchers from France and Hong Kong determined that transient elastography (TE), a noninvasive, ultrasonic imaging modality, can be accurately performed in the majority of patients with nonalcoholic fatty liver disease (NAFLD) to exclude advanced fibrosis. Full findings of this study, funded by the Chinese University of Hong Kong, appear in the February issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Biodesign Institute at Arizona State University associate research scientist Melha Mellata, a member of professor Roy Curtiss' team, is leading a USDA funded project to develop a vaccine against a leading poultry disease called avian pathogenic E. coli (APEC).
The Wall Street Journal: FDA is putting on workshops for pharmaceutical manufacturers to increase the pool of applicants for approved "orphan drugs," that treat rare diseases. Currently, there are about 7,000 so-called orphan diseases in the U.S. that have few or no FDA-approved treatments.
Planned births occur where a considered decision is made to deliver an infant, and in recent years there have been significant changes in clinical practice resulting in an increase in planned births before the ideal time of birth at 39-40 weeks' gestation.
› Verified 4 days ago
Brock Aaron Martin, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 550 S Jackson St, Louisville, KY 40202 Phone: 502-852-1816 | |
Mr. John R. Parker, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 530 S. Jackson St., Louisville, KY 40202 Phone: 502-852-6395 Fax: 502-852-1761 | |
Cynthia Romer Fata, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 231 E Chestnut St, Louisville, KY 40202 Phone: 502-456-6211 Fax: 502-456-4440 | |
Robin B Bideau, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 2307 Greene Way, Louisville, KY 40220 Phone: 502-897-9594 Fax: 502-736-4456 | |
Dr. Christopher M Kauffmann, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 4000 Kresge Way, Pathology Dept, Louisville, KY 40207 Phone: 502-897-8226 Fax: 502-897-8215 | |
William Byron Lockwood, MD, PHD Pathology Medicare: Not Enrolled in Medicare Practice Location: 530 S. Jackson St, Louisville, KY 40202 Phone: 502-852-6395 Fax: 502-852-1761 | |
Houda Alatassi, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 530 S Jackson St, Department Of Pathology And Laboratory Medicine, Louisville, KY 40202 Phone: 502-852-1762 Fax: 502-852-1761 |